脉血康胶囊联合阿司匹林治疗急性轻型卒中疗效观察

目的：探讨脉血康胶囊联合阿司匹林治疗急性轻型卒中的疗效。方法将191例急性轻型卒中患者随机分为脉血康组（62例）、双抗组（64例）和对照组（65例），脉血康组使用脉血康胶囊联合阿司匹林治疗，双抗组使用氯吡格雷联合阿司匹林治疗，对照组单用阿司匹林治疗，其余治疗均相同。结果脉血康组与双抗组治疗效果差异无统计学意义（P〉0.05），脉血康组与双抗组14、90d NIHSS评分均优于对照组（P〈0.05）。脉血康组病情进展的发生率低于对照组（P〈0.05），与双抗组差异无统计学意义（P〉0.05）。结论脉血康胶囊联合阿司匹林治疗轻型卒中疗效与氯吡格雷联合阿司匹林疗效相似，优于单用阿司匹林患者。

ObjectiveTo observe the effect of combined therapy of Maixuekang and aspirin on acute minor ischemic stroke.Methods191 patients with acute minor ischemic stroke were divided into Maixuekang group（combined therapy of Maixuekang and aspirin,n=62）,double anti-platelet group（combined therapy of aspirin and clopidogrel,n=64）and control group（therapy of aspirin only,n=65）.Other therapies were same in these patients except above.ResultsThe effect of Maixuekang group was as same as double anti-platelet group（P〉0.05）. NIHSS scores on 14d and 90d in Maixuekang group were lower than those in control group（P〈0.05）.The incidence of progression in Maixuekang group was lower than that in control group（P〈0.05）and as same as in double anti-platelet group（P〉0.05）.ConclusionsCombined therapy of Maixuekang and aspirin has better effect than therapy of aspirin in acute minor ischemic stroke,and has the same effect as combined therapy of aspirin and clopidogrel.